Dexcom G6 Intervention Study
Clinical Trial ID: NCT03877068
Description
The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour assessment of glucose values compared to Point of Care (POC) testing, during hospitalization and after hospital discharge in general medicine and surgery patients with T2D and T1D
The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour assessment of glucose values compared to Point of Care (POC) testing, during hospitalization and after hospital discharge in general medicine and surgery patients with T2D and T1D.
Criteria
Inclusion Criteria: 1. Males and females ≥ 18 years admitted to a general medicine or surgical services. 2. History of T1D or T2D receiving insulin therapy during hospital admission. 3. Subjects must have a randomization BG <400 mg/dL without laboratory evidence of diabetic ketoacidosis (bicarbonate < 18 mEq/L, pH < 7.30, or positive serum or urinary ketones). 4. Patients with expected hospital length-of-stay of 3 or more day Exclusion Criteria: 1. Patients with acute illness admitted to the ICU or expected to require admission to the ICU. 2. Patients expected to require MRI procedures during hospitalization. 3. Patients with clinically relevant hepatic disease (diagnosed liver cirrhosis and portal hypertension), corticosteroid therapy, end-stage renal disease (dialysis), or anasarca (massive peripheral edema). 4. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study. 5. Female subjects who are pregnant or breast‑feeding at time of enrollment into the study.
Start Date
2019-06-26
Last Updated
2019-12-12
Sponsor
Emory University
Condition Name
Diabetes Mellitus
Learn about this trial.
Check the eligibility requirements, study details, and more.
Related Trials
Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.